LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 140 filers reported holding LEGEND BIOTECH CORP in Q1 2022. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,986,895 | +5.9% | 74,243 | +8.8% | 0.01% | +12.5% |
Q2 2023 | $4,708,539 | +107.7% | 68,210 | +45.1% | 0.01% | +100.0% |
Q1 2023 | $2,267,402 | -16.3% | 47,022 | -13.3% | 0.00% | -33.3% |
Q4 2022 | $2,708,318 | +27.8% | 54,253 | +4.4% | 0.01% | +20.0% |
Q3 2022 | $2,120,000 | +17.3% | 51,965 | +58.2% | 0.01% | +25.0% |
Q2 2022 | $1,807,000 | +39.1% | 32,850 | -8.1% | 0.00% | +33.3% |
Q1 2022 | $1,299,000 | +16.0% | 35,735 | +48.7% | 0.00% | +50.0% |
Q4 2021 | $1,120,000 | +56.4% | 24,025 | +69.8% | 0.00% | 0.0% |
Q3 2021 | $716,000 | +28.5% | 14,153 | +4.3% | 0.00% | +100.0% |
Q2 2021 | $557,000 | – | 13,572 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |